Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Cheng, Yu Chen ^a   Sheen, Jer Ming ^b   Hu, Wen Long ^c   Hung, Yu Chiang ^d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CELL PROLIFERATION; NUTRITION; PATHOLOGY; PLATELETS;

ANTI OXIDATIVE ACTIVITY; CARDIO-VASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; INFLAMMATORY PROCESS; ISCHEMIC HEART DISEASE; LOW DENSITY LIPOPROTEINS; RADICAL SCAVENGING PROPERTIES; VASCULAR SMOOTH MUSCLE CELLS;

DISEASES;

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN; OXIDOREDUCTASE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MACROPHAGE; MONOCYTE; NONHUMAN; OBESITY; OXIDATION; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PATHOLOGY; SMOKING; THROMBOCYTE;

DISEASES; NUTRITION; OXIDATION; POLYPHENOLS; PROTEINS;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; HUMANS; LYMPHOCYTES; OXIDATIVE STRESS; POLYPHENOLS; REACTIVE OXYGEN SPECIES; SMOKING; STROKE;

EID: 85043262358     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/8526438     Document Type: Review

References (165)

1. W. Herrington, B. Lacey, P. Sherliker, J. Armitage, and S. Lewington, ?Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease,? Circulation Research, vol. 118, no. 4, pp. 535-546, 2016
2. S. Barquera, A. Pedroza-Tob?as, C. Medina et al., ?Global overview of the epidemiology of atherosclerotic cardiovascular disease,? Archives of Medical Research, vol. 46, no. 5, pp. 328-338, 2015
3. N. Inoue, ?Stress and atherosclerotic cardiovascular disease,? Journal of Atherosclerosis and Thrombosis, vol. 21, no. 5, pp. 391-401, 2014
4. I. Olmez and H. Ozyurt, ?Reactive oxygen species and ischemic cerebrovascular disease,? Neurochemistry International, vol. 60, no. 2, pp. 208-212, 2012
5. U. Forstermann, N. Xia, and H. Li, ?Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis,? Circulation Research, vol. 120, no. 4, pp. 713-735, 2017
6. R. Mia-Jeanne van and E. Pretorius, ?Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events,? Current Medicinal Chemistry, vol. 21, no. 19, pp. 2121-2129, 2014
7. J. Frohlich and A. Al-Sarraf, ?Cardiovascular risk and atherosclerosis prevention,? Cardiovascular Pathology, vol. 22, no. 1, pp. 16-18, 2013
8. N. Torres, M. Guevara-Cruz, L. A. Velazquez-Villegas, and A. R. Tovar, ?Nutrition and atherosclerosis,? Archives of Medical Research, vol. 46, no. 5, pp. 408-426, 2015
9. G. Vilahur and L. Badimon, ?Antiplatelet properties of natural products,? Vascular Pharmacology, vol. 59, no. 3-4, pp. 67-75, 2013
10. M. Massaro, E. Scoditti, M. A. Carluccio, and R. De Caterina, ?Nutraceuticals and prevention of atherosclerosis: focus on-3 polyunsaturated fatty acids and Mediterranean diet polyphenols,? Cardiovascular Therapeutics, vol. 28, no. 4, pp. e13-ee9, 2010
11. E. Brglez Mojzer, M. Knez Hrncic, M. Skerget, Z. Knez, and U. Bren, ?Polyphenols: extraction methods, antioxidative action, bioavailability and anticarcinogenic effects,? Molecules, vol. 21, no. 7, 2016
12. G. Pizzino, N. Irrera, M. Cucinotta et al., ?Oxidative stress: harms and benefits for human health,? Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8416763, 13 pages, 2017
13. K. K. Griendling and G. A. FitzGerald, ?Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS,? Circulation, vol. 108, no. 16, pp. 1912-1916, 2003
14. N. Panth, K. R. Paudel, and K. Parajuli, ?Reactive oxygen species: a key hallmark of cardiovascular disease,? Advances in Medicine, vol. 2016, Article ID 9152732, 12 pages, 2016
15. S. H. Choi, D. Sviridov, and Y. I. Miller, ?Oxidized cholesteryl esters and inflammation,? Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1862, no. 4, pp. 393-397, 2017
16. M. M. Elahi, Y. X. Kong, and B. M. Matata, ?Oxidative stress as a mediator of cardiovascular disease,? Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 259-269, 2009
17. R. W. O'Donnell, D. K. Johnson, L. M. Ziegler, A. J. DiMattina, R. I. Stone, and J. A. Holland, ?Endothelial NADPH oxidase: mechanism of activation by low-density lipoprotein,? Endothelium, vol. 10, no. 6, pp. 291-297, 2003
18. F. L. Song, R. Y. Gan, Y. Zhang, Q. Xiao, L. Kuang, and H. B. Li, ?Total phenolic contents and antioxidant capacities of selected Chinese medicinal plants,? International Journal of Molecular Sciences, vol. 11, no. 6, pp. 2362-2372, 2010
19. S. Dragland, H. Senoo, K. Wake, K. Holte, and R. Blomhoff, ?Several culinary and medicinal herbs are important sources of dietary antioxidants,? The Journal of Nutrition, vol. 133, no. 5, pp. 1286-1290, 2003
20. Y. Cai, Q. Luo, M. Sun, and H. Corke, ?Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer,? Life Sciences, vol. 74, no. 17, pp. 2157-2184, 2004
21. V. Neveu, J. Perez-Jimenez, F. Vos et al., ?Phenol-explorer: an online comprehensive database on polyphenol contents in foods,? Database, vol. 2010, article bap024, 2010
22. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, ?Polyphenols: food sources and bioavailability,? The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727-747, 2004
23. K. B. Pandey and S. I. Rizvi, ?Plant polyphenols as dietary antioxidants in human health and disease,? Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270-278, 2009
24. R. Tsao, ?Chemistry and biochemistry of dietary polyphenols,? Nutrients, vol. 2, no. 12, pp. 1231-1246, 2010
25. G. Williamson and C. Manach, ?Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies,? The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 243S-255S, 2005
26. S. Ramos, ?Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways,? Molecular Nutrition & Food Research, vol. 52, no. 5, pp. 507-526, 2008
27. M. Biesaga, ?Influence of extraction methods on stability of flavonoids,? Journal of Chromatography A, vol. 1218, no. 18, pp. 2505-2512, 2011
28. A. Scalbert, I. T. Johnson, and M. Saltmarsh, ?Polyphenols: antioxidants and beyond,? The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 215S-217S, 2005
29. B. Halliwell, J. Rafter, and A. Jenner, ?Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not?,? The American Journal of Clinical Nutrition, vol. 81, Supplement 1, pp. 268s-276s, 2005
30. J. O. Moskaug, H. Carlsen, M. C. Myhrstad, and R. Blomhoff, ?Polyphenols and glutathione synthesis regulation,? The American Journal of Clinical Nutrition, vol. 81, Supplement 1, pp. 277s-283s, 2005
31. C. C. Chuang and M. K. McIntosh, ?Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases,? Annual Review of Nutrition, vol. 31, pp. 155-176, 2011
32. E. Middleton Jr.C. Kandaswami and T. C. Theoharides, ?The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,? Pharmacological Reviews, vol. 52, no. 4, pp. 673-751, 2000
33. H. Yoshida, T. Ishikawa, H. Hosoai et al., ?Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein,? Biochemical Pharmacology, vol. 58, no. 11, pp. 1695-1703, 1999
34. N. R. Perron and J. L. Brumaghim, ?A review of the antioxidant mechanisms of polyphenol compounds related to iron binding,? Cell Biochemistry and Biophysics, vol. 53, no. 2, pp. 75-100, 2009
35. I. Bernatova, O. Pechanova, P. Babal, S. Kysela, S. Stvrtina, and R. Andriantsitohaina, ?Wine polyphenols improve cardiovascular remodeling and vascular function in NOdeficient hypertension,? American Journal of Physiology-Heart and Circulatory Physiology, vol. 282, no. 3, pp. H942-H948, 2002
36. O. Pechanova, I. Bernatova, P. Babal et al., ?Red wine polyphenols prevent cardiovascular alterations in L-NAMEinduced hypertension,? Journal of Hypertension, vol. 22, no. 8, pp. 1551-1559, 2004
37. F. Fyhrquist, K. Metsarinne, and I. Tikkanen, ?Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders,? Journal of Human Hypertension, vol. 9, Supplement 5, pp. S19-S24, 1995
38. M. Sarr, M. Chataigneau, S. Martins et al., ?Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase,? Cardiovascular Research, vol. 71, no. 4, pp. 794-802, 2006
39. C. M. Lin, S. W. Hou, B. W. Wang, J. R. Ong, H. Chang, and K. G. Shyu, ?Molecular mechanism of ()-epigallocatechin-3-gallate on balloon injury-induced neointimal formation and leptin expression,? Journal of Agricultural and Food Chemistry, vol. 62, no. 6, pp. 1213-1220, 2014
40. R. El Bekay, M. Alvarez, J. Monteseir?n et al., ?Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-Activated protein kinase, calcineurin, and the transcription factor NF-B,? Blood, vol. 102, no. 2, pp. 662-671, 2003
41. K. Ried, T. R. Sullivan, P. Fakler, O. R. Frank, and N. P. Stocks, ?Effect of cocoa on blood pressure,? The Cochrane Database of Systematic Reviews, no. 8, article Cd008893, 2012
42. A. Rostami, M. Khalili, N. Haghighat et al., ?High-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension,? ARYA Atherosclerosis, vol. 11, no. 1, pp. 21-29, 2015
43. M. M. de Jesus Romero-Prado, J. A. Curiel-Beltran, M. V. Miramontes-Espino, E. G. Cardona-Munoz, A. Rios-Arellano, and L. B. Balam-Salazar, ?Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure,? Basic & Clinical Pharmacology & Toxicology, vol. 117, no. 1, pp. 57-64, 2015
44. E. Toledo, F. B. Hu, R. Estruch et al., ?Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial,? BMC Medicine, vol. 11, p. 207, 2013
45. D. Grassi, R. Draijer, C. Schalkwijk et al., ?Black tea increases circulating endothelial progenitor cells and improves flow mediated dilatation counteracting deleterious effects from a fat load in hypertensive patients: a randomized controlled study,? Nutrients, vol. 8, no. 11, 2016
46. E. Grossman, ?Does increased oxidative stress cause hypertension?,? Diabetes Care, vol. 31, Supplement 2, pp. S185-S189, 2008
47. N. C. Ward, J. M. Hodgson, K. D. Croft, V. Burke, L. J. Beilin, and I. B. Puddey, ?The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial,? Journal of Hypertension, vol. 23, no. 2, pp. 427-434, 2005
48. D. Grassi, C. Lippi, S. Necozione, G. Desideri, and C. Ferri, ?Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons,? The American Journal of Clinical Nutrition, vol. 81, no. 3, pp. 611-614, 2005
49. N. Houstis, E. D. Rosen, and E. S. Lander, ?Reactive oxygen species have a causal role in multiple forms of insulin resistance,? Nature, vol. 440, no. 7086, pp. 944-948, 2006
50. N. Suganya, E. Bhakkiyalakshmi, D. V. Sarada, and K. M. Ramkumar, ?Reversibility of endothelial dysfunction in diabetes: role of polyphenols,? British Journal of Nutrition, vol. 116, no. 2, pp. 223-246, 2016
51. B. Lipinski, ?Pathophysiology of oxidative stress in diabetes mellitus,? Journal of Diabetes and its Complications, vol. 15, no. 4, pp. 203-210, 2001
52. N. Sasaki, T. Yamashita, T. Takaya et al., ?Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus,? Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 6, pp. 1068-1076, 2008
53. S. Gupta, E. Chough, J. Daley et al., ?Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity,? American Journal of Physiology-Cell Physiology, vol. 282, no. 3, pp. C560-C5C6, 2002
54. K. Monaghan, J. McNaughten, M. K. McGahon et al., ?Hyperglycemia and diabetes downregulate the functional expression of TRPV4 channels in retinal microvascular endothelium,? PLoS One, vol. 10, no. 6, article e0128359, 2015
55. J. M. Gomes, J. A. Costa, and R. C. Alfenas, ?Metabolic endotoxemia and diabetes mellitus: a systematic review,? Metabolism, vol. 68, pp. 133-144, 2017
56. F. Le Sage, O. Meilhac, and M. P. Gonthier, ?Anti-inflammatory and antioxidant effects of polyphenols extracted from Antirhea borbonica medicinal plant on adipocytes exposed to Porphyromonas gingivalis and Escherichia coli lipopolysaccharides,? Pharmacological Research, vol. 119, pp. 303-312, 2017
57. L. P. Aiello and J. S. Wong, ?Role of vascular endothelial growth factor in diabetic vascular complications,? Kidney International, vol. 58, Supplement 77, pp. S113-S119, 2000
58. T. Mrudula, P. Suryanarayana, P. N. Srinivas, and G. B. Reddy, ?Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocininduced diabetic rat retina,? Biochemical and Biophysical Research Communications, vol. 361, no. 2, pp. 528-532, 2007
59. T. Sawatpanich, H. Petpiboolthai, B. Punyarachun, and V. Anupunpisit, ?Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin,? Journal of the Medical Association of Thailand, vol. 93, Supplement 2, pp. S1-S8, 2010
60. J. Y. Shin, J. Sohn, and K. H. Park, ?Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model,? Journal of Korean Medical Science, vol. 28, no. 4, pp. 608-613, 2013
61. A. W. Zieske, G. T. Malcom, and J. P. Strong, ?Natural history and risk factors of atherosclerosis in children and youth: the PDAY study,? Pediatric Pathology & Molecular Medicine, vol. 21, no. 2, pp. 213-237, 2002
62. M. L. Kortelainen and T. Sarkioja, ?Visceral fat and coronary pathology in male adolescents,? International Journal of Obesity, vol. 25, no. 2, pp. 228-232, 2001
63. M. Hulsmans and P. Holvoet, ?The vicious circle between oxidative stress and inflammation in atherosclerosis,? Journal of Cellular and Molecular Medicine, vol. 14, no. 1-2, pp. 70-78, 2010
64. J. K. Lin and S. Y. Lin-Shiau, ?Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols,? Molecular Nutrition & Food Research, vol. 50, no. 2, pp. 211-217, 2006
65. M. Daval, F. Diot-Dupuy, R. Bazin et al., ?Anti-lipolytic action of AMP-Activated protein kinase in rodent adipocytes,? The Journal of Biological Chemistry, vol. 280, no. 26, pp. 25250-25257, 2005
66. C. L. Lin, H. C. Huang, and J. K. Lin, ?Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells,? Journal of Lipid Research, vol. 48, no. 11, pp. 2334-2343, 2007
67. H.-J. Ko, C.-Y. Lo, B.-J. Wang, R. Y.-Y. Chiou, and S.-M. Lin, ?Theaflavin-3,3-digallate, a black tea polyphenol, stimulates lipolysis associated with the induction of mitochondrial uncoupling proteins and AMPK-FoxO3A-MnSOD pathway in 3T3-L1 adipocytes,? Journal of Functional Foods, vol. 17, pp. 271-282, 2015
68. Y. Shishikura, S. Khokhar, and B. S. Murray, ?Effects of tea polyphenols on emulsification of olive oil in a small intestine model system,? Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1906-1913, 2006
69. M. A. Vermeer, T. P. Mulder, and H. O. Molhuizen, ?Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles,? Journal of Agricultural and Food Chemistry, vol. 56, no. 24, pp. 12031-12036, 2008
70. S. Uchiyama, Y. Taniguchi, A. Saka, A. Yoshida, and H. Yajima, ?Prevention of diet-induced obesity by dietary black tea polyphenols extract in vitro and in vivo,? Nutrition, vol. 27, no. 3, pp. 287-292, 2011
71. H. Ashigai, Y. Taniguchi, M. Suzuki et al., ?Fecal lipid excretion after consumption of a black tea polyphenol containing beverage-randomized, placebo-controlled, double-blind, crossover study,? Biological & Pharmaceutical Bulletin, vol. 39, no. 5, pp. 699-704, 2016
72. T. F. Hsu, A. Kusumoto, K. Abe et al., ?Polyphenol-enriched oolong tea increases fecal lipid excretion,? European Journal of Clinical Nutrition, vol. 60, no. 11, pp. 1330-1336, 2006
73. Y. Hosoyamada and M. Yamada, ?Effects of dietary fish oil and apple polyphenol on the concentration serum lipids and excretion of fecal bile acids in rats,? Journal of Nutritional Science and Vitaminology, vol. 63, no. 1, pp. 21-27, 2017
74. ?Obesity and overweight: WHO fact sheet,? 2016, http://who. int/mediacentre/factsheets/fs311/en/
75. J. M. Genkinger, C. M. Kitahara, L. Bernstein et al., ?Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies,? Annals of Oncology, vol. 26, no. 11, pp. 2257-2266, 2015
76. R. H. Eckel and R. M. Krauss, ?American Heart Association call to action: obesity as a major risk factor for coronary heart disease,? Circulation, vol. 97, no. 21, pp. 2099-2100, 1998
77. P. Poirier, T. D. Giles, G. A. Bray et al., ?Obesity and cardiovascular disease,? Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 968-976, 2006
78. H. K. Vincent and A. G. Taylor, ?Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans,? International Journal of Obesity, vol. 30, no. 3, pp. 400-418, 2006
79. H. Pan, Y. Gao, and Y. Tu, ?Mechanisms of body weight reduction by black tea polyphenols,? Molecules, vol. 21, no. 12, 2016
80. B. L. Wajchenberg, ?Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome,? Endocrine Reviews, vol. 21, no. 6, pp. 697-738, 2000
81. S. de Ferranti and D. Mozaffarian, ?The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences,? Clinical Chemistry, vol. 54, no. 6, pp. 945-955, 2008
82. B. B. Kahn and J. S. Flier, ?Obesity and insulin resistance,? Journal of Clinical Investigation, vol. 106, no. 4, pp. 473-481, 2000
83. C. L. Shen, J. J. Cao, R. Y. Dagda et al., ?Green tea polyphenols benefits body composition and improves bone quality in long-term high-fat diet-induced obese rats,? Nutrition Research, vol. 32, no. 6, pp. 448-457, 2012
84. H. W. Chen, M. L. Chien, Y. H. Chaung, C. K. Lii, and T. S. Wang, ?Extracts from cigarette smoke induce DNA damage and cell adhesion molecule expression through different pathways,? Chemico-Biological Interactions, vol. 150, no. 3, pp. 233-241, 2004
85. M. Hossain, T. Sathe, V. Fazio et al., ?Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier,? Brain Research, vol. 1287, pp. 192-205, 2009
86. P. Naik, N. Fofaria, S. Prasad et al., ?Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?,? BMC Neuroscience, vol. 15, p. 51, 2014
87. A. Sobczak, D. Golka, and I. Szoltysek-Boldys, ?The effects of tobacco smoke on plasma alpha-And gamma-tocopherol levels in passive and active cigarette smokers,? Toxicology Letters, vol. 151, no. 3, pp. 429-437, 2004
88. M. Dietrich, G. Block, E. P. Norkus et al., ?Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase-tocopherol in vivo after adjustment for dietary antioxidant intakes,? The American Journal of Clinical Nutrition, vol. 77, no. 1, pp. 160-166, 2003
89. B. Isik, A. Ceylan, and R. Isik, ?Oxidative stress in smokers and non-smokers,? Inhalation Toxicology, vol. 19, no. 9, pp. 767-9, 2007
90. T. Masubuchi, S. Koyama, E. Sato et al., ?Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity,? The American Journal of Pathology, vol. 153, no. 6, pp. 1903-1912, 1998
91. I. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, ?Evaluation of oxidative stress in patients with acute ischemic stroke,? Romanian journal of internal medicine = Revue roumaine de medecine interne, vol. 51, no. 2, pp. 97-106, 2013
92. T. Mannami, H. Iso, S. Baba et al., ?Cigarette smoking and risk of stroke and its subtypes among middle-Aged Japanese men and women: the JPHC study cohort I,? Stroke, vol. 35, no. 6, pp. 1248-1253, 2004
93. J. S. Gill, M. J. Shipley, S. A. Tsementzis et al., ?Cigarette smoking. A risk factor for hemorrhagic and nonhemorrhagic stroke,? Archives of Internal Medicine, vol. 149, no. 9, pp. 2053-2057, 1989
94. M. Hossain, P. Mazzone, W. Tierney, and L. Cucullo, ?In vitro assessment of tobacco smoke toxicity at the BBB: do antioxidant supplements have a protective role?,? BMC Neuroscience, vol. 12, p. 92, 2011
95. S. Prasad, R. K. Sajja, M. A. Kaisar et al., ?Role of Nrf2 and protective effects of metformin against tobacco smokeinduced cerebrovascular toxicity,? Redox Biology, vol. 12, pp. 58-69, 2017
96. J. K. Willcox, S. L. Ash, and G. L. Catignani, ?Antioxidants and prevention of chronic disease,? Critical Reviews in Food Science and Nutrition, vol. 44, no. 4, pp. 275-295, 2004
97. C. Del Bo, M. Porrini, D. Fracassetti, J. Campolo, D. Klimis-Zacas, and P. Riso, ?A single serving of blueberry (V. corymbosum) modulates peripheral arterial dysfunction induced by acute cigarette smoking in young volunteers: a randomized-controlled trial,? Food & Function, vol. 5, no. 12, pp. 3107-3116, 2014
98. C. Sticozzi, F. Cervellati, X. M. Muresan, C. Cervellati, and G. Valacchi, ?Resveratrol prevents cigarette smoke-induced keratinocytes damage,? Food & Function, vol. 5, no. 9, pp. 2348-2356, 2014
99. M. J. Bao, J. Shen, Y. L. Jia et al., ?Apple polyphenol protects against cigarette smoke-induced acute lung injury,? Nutrition, vol. 29, no. 1, pp. 235-243, 2013
100. J. C. Lee, J. T. Laydon, P. C. McDonnell et al., ?A protein kinase involved in the regulation of inflammatory cytokine biosynthesis,? Nature, vol. 372, no. 6508, pp. 739-746, 1994
101. C. Qing, P. Chen, and X. Xiang, ?Effect of tea polyphenols on oxidative damage and apoptosis in human bronchial epithelial cells induced by low-dose cigarette smoke condensate,? Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences, vol. 35, no. 2, pp. 123-128, 2010
102. W. C. Aird, ?Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms,? Circulation Research, vol. 100, no. 2, pp. 158-173, 2007
103. H. Lum and K. A. Roebuck, ?Oxidant stress and endothelial cell dysfunction,? American Journal of physiology Cell physiology, vol. 280, no. 4, pp. C719-C741, 2001
104. S. M. Davidson and M. R. Duchen, ?Endothelial mitochondria: contributing to vascular function and disease,? Circulation Research, vol. 100, no. 8, pp. 1128-1141, 2007
105. A. J. Flammer, T. Anderson, D. S. Celermajer et al., ?The assessment of endothelial function: from research into clinical practice,? Circulation, vol. 126, no. 6, pp. 753-767, 2012
106. H. A. Hadi, C. S. Carr, and J. Al Suwaidi, ?Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome,? Vascular Health and Risk Management, vol. 1, no. 3, pp. 183-198, 2005
107. C. E. Storniolo, J. Rosello-Catafau, X. Pinto, M. T. Mitjavila, and J. J. Moreno, ?Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1,? Redox Biology, vol. 2, pp. 971-977, 2014
108. M. B. Engler, M. M. Engler, C. Y. Chen et al., ?Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults,? Journal of the American College of Nutrition, vol. 23, no. 3, pp. 197-204, 2004
109. D. F. Fitzpatrick, S. L. Hirschfield, T. Ricci, P. Jantzen, and R. G. Coffey, ?Endothelium-dependent vasorelaxation caused by various plant extracts,? Journal of Cardiovascular Pharmacology, vol. 26, no. 1, pp. 90-95, 1995
110. D. Steinberg, S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum, ?Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity,? New England Journal of Medicine, vol. 320, no. 14, pp. 915-924, 1989
111. D. Steinberg, ?The LDL modification hypothesis of atherogenesis: an update,? Journal of Lipid Research, vol. 50, pp. S376-SS81, 2009
112. D. Steinberg and J. L. Witztum, ?Oxidized low-density lipoprotein and atherosclerosis,? Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 12, pp. 2311-2316, 2010
113. N. Santanam and S. Parthasarathy, ?Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases,? Journal of Clinical Investigation, vol. 95, no. 6, pp. 2594-2600, 1995
114. G. Maiolino, G. Rossitto, P. Caielli, V. Bisogni, G. P. Rossi, and L. A. Calo, ?The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts,? Mediators of Inflammation, vol. 2013, Article ID 714653, 13 pages, 2013
115. B. Simini, ?Serge Renaud: from French paradox to Cretan miracle,? The Lancet, vol. 355, no. 9197, p. 48, 2000
116. E. N. Frankel, J. Kanner, J. B. German, E. Parks, and J. E. Kinsella, ?Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine,? The Lancet, vol. 341, no. 8843, pp. 454-457, 1993
117. J. H. Chen, M. S. Lee, C. P. Wang, C. C. Hsu, and H. H. Lin, ?Autophagic effects of Hibiscus sabdariffa leaf polyphenols and epicatechin gallate (ECG) against oxidized LDLinduced injury of human endothelial cells,? European Journal of Nutrition, vol. 56, no. 5, pp. 1963-1981, 2017
118. N. Suzuki-Sugihara, Y. Kishimoto, E. Saita et al., ?Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans,? Nutrition Research, vol. 36, no. 1, pp. 16-23, 2016
119. C. Knall, G. S. Worthen, and G. L. Johnson, ?Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-Activated protein kinases,? Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3052-7, 1997
120. Y. Imai and D. R. Clemmons, ?Roles of phosphatidylinositol 3-kinase and mitogen-Activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I,? Endocrinology, vol. 140, no. 9, pp. 4228-4235, 1999
121. J. C. Hedges, M. A. Dechert, I. A. Yamboliev et al., ?A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration,? Journal of Biological Chemistry, vol. 274, no. 34, pp. 24211-24219, 1999
122. S. Rosenkranz, D. Knirel, H. Dietrich, M. Flesch, E. Erdmann, and M. Bohm, ?Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the ?French paradox?,? The FASEB Journal, vol. 16, no. 14, pp. 1958-1960, 2002
123. M. Dell'Agli, A. Busciala, and E. Bosisio, ?Vascular effects of wine polyphenols,? Cardiovascular Research, vol. 63, no. 4, pp. 593-602, 2004
124. H. C. Lin, M. J. Hsieh, C. H. Peng, S. F. Yang, and C. N. Huang, ?Pterostilbene inhibits vascular smooth muscle cells migration and matrix metalloproteinase-2 through modulation of MAPK pathway,? Journal of Food Science, vol. 80, no. 10, pp. H2331-H2335, 2015
125. M. Wicinski, B. Malinowski, M. M. Weclewicz, E. Grzesk, and G. Grzesk, ?Resveratrol increases serum BDNF concentrations and reduces vascular smooth muscle cells contractility via a NOS-3-independent mechanism,? BioMed Research International, vol. 2017, Article ID 9202954, 7 pages, 2017
126. H. Y. Li, M. Yang, Z. Li, and Z. Meng, ?Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-Activity and reducing oxidative stress,? International Journal of Molecular Medicine, vol. 39, no. 5, pp. 1307-1316, 2017
127. K. Shimada, ?Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis,? Circulation Journal, vol. 73, no. 6, pp. 994-1001, 2009
128. K. J. Moore and I. Tabas, ?Macrophages in the pathogenesis of atherosclerosis,? Cell, vol. 145, no. 3, pp. 341-355, 2011
129. O. Rom, H. Korach-Rechtman, T. Hayek et al., ?Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice,? Archives of Toxicology, vol. 91, no. 4, pp. 1709-1725, 2017
130. S. Sarkar, A. A. Siddiqui, S. Mazumder et al., ?Ellagic acid, a dietary polyphenol, inhibits tautomerase activity of human macrophage migration inhibitory factor and its pro-inflammatory responses in human peripheral blood mononuclear cells,? Journal of Agricultural and Food Chemistry, vol. 63, no. 20, pp. 4988-4998, 2015
131. E. Scoditti, A. Nestola, M. Massaro et al., ?Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKC? and PKCβ1 inhibition,? Atherosclerosis, vol. 232, no. 1, pp. 17-24, 2014
132. L. N. Broekhuizen, D. F. van Wijk, H. Vink et al., ?Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors,? British Journal of Nutrition, vol. 106, no. 9, pp. 1416-1422, 2011
133. C. T. Ford, S. Richardson, F. McArdle et al., ?Identification of (poly)phenol treatments that modulate the release of proinflammatory cytokines by human lymphocytes,? British Journal of Nutrition, vol. 115, no. 10, pp. 1699-1710, 2016
134. C. Faggio, A. Sureda, S. Morabito et al., ?Flavonoids and platelet aggregation: a brief review,? European Journal of Pharmacology, vol. 807, pp. 91-101, 2017
135. G. E. Hirsch, P. R. Viecili, A. S. de Almeida et al., ?Natural products with antiplatelet action,? Current Pharmaceutical Design, vol. 23, no. 8, pp. 1228-1246, 2017
136. T. Mattiello, E. Trifiro, G. S. Jotti, and F. M. Pulcinelli, ?Effects of pomegranate juice and extract polyphenols on platelet function,? Journal of Medicinal Food, vol. 12, no. 2, pp. 334-339, 2009
137. D. A. Pearson, T. G. Paglieroni, D. Rein et al., ?The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function,? Thrombosis Research, vol. 106, no. 4-5, pp. 191-197, 2002
138. D. Rein, T. G. Paglieroni, T. Wun et al., ?Cocoa inhibits platelet activation and function,? The American Journal of Clinical Nutrition, vol. 72, no. 1, pp. 30-35, 2000
139. R. R. Holt, D. D. Schramm, C. L. Keen, S. A. Lazarus, and H. H. Schmitz, ?Chocolate consumption and platelet function,? JAMA, vol. 287, no. 17, pp. 2212-2213, 2002
140. G. Rull, Z. N. Mohd-Zain, J. Shiel et al., ?Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation,? Vascular Pharmacology, vol. 71, pp. 70-78, 2015
141. R. Carnevale, L. Loffredo, P. Pignatelli et al., ?Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers,? Journal of Thrombosis and Haemostasis, vol. 10, no. 1, pp. 125-132, 2012
142. E. Saita, K. Kondo, and Y. Momiyama, ?Anti-inflammatory diet for atherosclerosis and coronary artery disease: antioxidant foods,? Clinical Medicine Insights Cardiology, vol. 8, Supplement 3, pp. 61-65, 2015
143. Y. Kokubo, H. Iso, J. Ishihara, K. Okada, M. Inoue, and S. Tsugane, ?Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan public health centerbased (JPHC) study cohort I,? Circulation, vol. 116, no. 22, pp. 2553-2562, 2007
144. H. N. Hodis, W. J. Mack, N. Kono et al., ?Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial,? Stroke, vol. 42, no. 11, pp. 3168-3175, 2011
145. D. Pala, P. O. Barbosa, C. T. Silvaet al., ?Acai (Euterpe oleracea Mart.) dietary intake affects plasma lipids, apolipoproteins, cholesteryl ester transfer to high-density lipoprotein and redox metabolism: a prospective study in women,? Clinical Nutrition, 2017
146. T. Namekata, K. Suzuki, N. Ishizuka, and K. Shirai, ?Establishing baseline criteria of cardio-Ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study,? BMC Cardiovascular Disorders, vol. 11, no. 1, p. 51, 2011
147. H. Imamura, T. Yamaguchi, D. Nagayama, A. Saiki, K. Shirai, and I. Tatsuno, ?Resveratrol ameliorates arterial stiffness assessed by cardio-Ankle vascular index in patients with type 2 diabetes mellitus,? International Heart Journal, vol. 58, no. 4, pp. 577-583, 2017
148. C. Pasten, N. C. Olave, L. Zhou, E. M. Tabengwa, P. E. Wolkowicz, and H. E. Grenett, ?Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: molecular contributor to cardiovascular protection,? Thrombosis Research, vol. 121, no. 1, pp. 59-65, 2007
149. A. Sinkovic, D. Suran, L. Lokar et al., ?Rosemary extracts improve flow-mediated dilatation of the brachial artery and plasma PAI-1 activity in healthy young volunteers,? Phytotherapy Research, vol. 25, no. 3, pp. 402-407, 2011
150. J. Lekakis, L. S. Rallidis, I. Andreadou et al., ?Polyphenols compounds from red grapes acutely improve endothelial function in patients with coronary heart disease,? European Journal of Cardiovascular Prevention & Rehabilitation, vol. 12, no. 6, pp. 596-600, 2005
151. K. Magyar, R. Halmosi, A. Palfi et al., ?Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease,? Clinical Hemorheology and Microcirculation, vol. 50, no. 3, pp. 179-187, 2012
152. M. G. Hertog, E. J. Feskens, P. C. Hollman, M. B. Katan, and D. Kromhout, ?Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study,? The Lancet, vol. 342, no. 8878, pp. 1007-1011, 1993
153. P. Knekt, R. Jarvinen, A. Reunanen, and J. Maatela, ?Flavonoid intake and coronary mortality in Finland: a cohort study,? BMJ, vol. 312, no. 7029, pp. 478-481, 1996
154. P. J. Mink, C. G. Scrafford, L. M. Barraj et al., ?Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women,? The American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 895-909, 2007
155. S. R. Hsieh, W. C. Cheng, Y. M. Su, C. H. Chiu, and Y. M. Liou, ?Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury,? BioMedicine, vol. 4, p. 23, 2014
156. H. T. Lai, D. E. Threapleton, A. J. Day, G. Williamson, J. E. Cade, and V. J. Burley, ?Fruit intake and cardiovascular disease mortality in the UK Women?s cohort study,? European Journal of Epidemiology, vol. 30, no. 9, pp. 1035-1048, 2015
157. M. A. Martinez-Gonzalez, J. Salas-Salvado, R. Estruch, D. Corella, M. Fito, and E. Ros, ?Benefits of the Mediterranean diet: insights from the PREDIMED study,? Progress in Cardiovascular Diseases, vol. 58, no. 1, pp. 50-60, 2015
158. ?The top 10 causes of death: WHO, fact sheet,? 2017, http://who.int/mediacentre/factsheets/fs310/en/
159. S. M. A. A. Evers, J. N. Struijs, A. J. H. A. Ament, M. L. L. van Genugten, J. C. Jager, and G. A. M. van den Bos, ?International comparison of stroke cost studies,? Stroke, vol. 35, no. 5, pp. 1209-1215, 2004
160. D. Wan, Y. Zhou, K. Wang, Y. Hou, R. Hou, and X. Ye, ?Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats,? Brain Research Bulletin, vol. 121, pp. 255-262, 2016
161. V. Carito, M. Ceccanti, L. Tarani, G. Ferraguti, G. N. Chaldakov, and M. Fiore, ?Neurotrophins? modulation by olive polyphenols,? Current Medicinal Chemistry, vol. 23, no. 28, pp. 3189-3197, 2016
162. I. L. Hung, Y. C. Hung, L. Y. Wang et al., ?Chinese herbal products for ischemic stroke,? The American Journal of Chinese Medicine, vol. 43, no. 7, pp. 1365-1379, 2015
163. Z. M. Wang, D. Zhao, Z. L. Nie et al., ?Flavonol intake and stroke risk: a meta-Analysis of cohort studies,? Nutrition, vol. 30, no. 5, pp. 518-523, 2014
164. M. E. Goetz, S. E. Judd, T. J. Hartman, W. McClellan, A. Anderson, and V. Vaccarino, ?Flavanone intake is inversely associated with risk of incident ischemic stroke in the REasons for geographic and racial differences in stroke (REGARDS) study,? Journal of Nutrition, vol. 146, no. 11, pp. 2233-2243, 2016
165. C. C. Chang, Y. C. Chang, W. L. Hu, and Y. C. Hung, ?Oxidative stress and Salvia miltiorrhiza in aging-Associated cardiovascular diseases,? Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4797102, 11 pages, 2016.